Inventor

Peter Vanlandschoot

Inventor

Bellem, BE

Overview

2013–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 21 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary

C07KPeptides37%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%

A61KPreparations for medical, dental or toiletry purposes26%

A61MDevices for introducing media into, or onto, the body4%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%

Y02ATechnologies for adaptation to climate change2%

PatentTitleYear

11,098,113Immunoglobulin single variable domains directed against macrophage migration inhibitory factor2021 11,046,773Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity2021 10,550,174Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases2020 10,407,492Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases2019 10,273,305Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity2019 9,994,639Biological materials related to CXCR72018 9,834,595Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases2017 9,822,175'Amino acid sequences directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis'2017 9,803,018'Amino acid sequences directed against cellular receptors for viruses and bacteria'2017 9,758,584'Biological materials related to CXCR7'2017 9,725,522'Pulmonary administration of immunoglobulin single variable domains and constructs thereof'2017 9,512,236'Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders'2016 9,382,333'Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis'2016 9,320,792'Pulmonary administration of immunoglobulin single variable domains and constructs thereof'2016 9,212,226'Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the same'2015 9,193,780'Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases'2015 9,034,325'Amino acid sequences directed against multitarget scavenger receptors and polypeptides'2015 9,005,963'Amino acid sequences directed against cellular receptors for viruses and bacteria'2015 8,937,164'Biological materials related to CXCR7'2015 8,858,940'Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis'2014 8,557,965'Single variable domains against notch pathway members'2013

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2013–2021Patents assigned to ABLYNX NV (19)· patent assignee history

2013–2015Patents assigned to VANLANDSCHOOT PETER (7)· patent assignee history

2013–2015Patents assigned to DE HAARD JOHANNES JOSEPH WILHELMUS (5)· patent assignee history

2013–2015Patents assigned to SAUNDERS MICHAEL JOHN SCOTT (5)· patent assignee history

2013–2021Based in Bellem, BE· patent location history

2015Patents assigned to LEURS REGORIUS (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ABLYNX NV	19	2013–2021
VANLANDSCHOOT PETERself	7	2013–2015
DE HAARD JOHANNES JOSEPH WILHELMUS	5	2013–2015
SAUNDERS MICHAEL JOHN SCOTT	5	2013–2015
LEURS REGORIUS	3	2015

Locations

Location	Patents	Span
Bellem, BE	21	2013–2021